[1] Guo L, Jia P, Hu YC, et al.Measurement of morphological parameters of giant cell tumor of bone in the knee[J]. Oncol Lett,2019,17(4):3867-3873.
[2] van der Heijden L, Dijkstra PD, Campanacci DA, et al. Giant cell tumor with pathologic fracture: should we curette or resect?[J]. Clin Orthop Relat Res, 2013, 471(3): 820-829.
[3] 中华医学会骨科学分会骨肿瘤学组. 中国骨巨细胞瘤临床诊疗指南[J]. 中华骨科杂志, 2018, 38(14):833-840.
[4] Palmerini E,Righi A, Staals EL.Rare Primary Malignant Bone Sarcomas[J].Cancers(Basel),2020,12(11):3092.
[5] Futani H, Kumanishi S, Minakawa GO,et al.Osteoscopic Surgery of Giant Cell Tumor of Bone for Preservation of Proximal Fibula[J]. Anticancer Res, 2018, 38(5):2995-3000.
[6] Tolk JJ,van der Steen MC,Janssen RPA,et al. Total Knee Arthroplasty: What to Expect? A Survey of the Members of the Dutch Knee Society on Long-Term Recovery after Total Knee Arthroplasty[J].J Knee Surg, 2017, 30(6):612-616.
[7] 高云. 快速康复理念在骨肉瘤人工膝关节置换术围术期中应用[J]. 临床军医杂志, 2017,45(5):517-519.
[8] 陈佳佳, 童莺歌, 黎晓艳,等. 我国三级甲等医院护士疼痛护理实践现状及影响因素[J]. 护理研究, 2017, 31(33):4193-4198.
[9] 李栋,马焕芝,张伟,等. 肿瘤型铰链式人工膝关节置换术后假体相关并发症分析[J]. 中国修复重建外科杂志, 2015,29(8):936-940.
[10] 张丹妹,赵艳丽,冯志军. 预防人工关节置换术后下肢深静脉血栓形成研究进展[J].临床误诊误治, 2019, 32(2):111-116.
[11] 耿磊, 张浩强, 王臻,等. 膝关节周围骨巨细胞瘤人工关节置换术后疗效评价[J]. 中国骨与关节杂志, 2016, 5(1):14-18.
[12] Nakamura T, Matsumine A, Uchida A, et al.Clinical outcomes of kyocera modular limb salvage system after resection of bone sarcoma of the distal part of the femur: the Japanese Musculoskeletal Oncology Group study[J]. Int Orthop, 2014, 38(4): 825-830. |
津公网安备12010402001915